Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens
Authors:
- 1 April 1994
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 32 (4) , 971-4
Abstract
An enzyme-linked immunosorbent assay (ELISA) was developed for detecting antibodies against Trypanosoma cruzi. Two synthetic T. cruzi peptides, TcD and PEP2, were used. The specificity and sensitivity of the peptide ELISA were determined with 260 serum samples from individuals living in an area in which Chagas' disease is endemic. ELISAs were performed with the peptides singly or in combination. The evaluation of these tests showed that 168 (93.8%) of 179 serum samples from T. cruzi-infected patients were positive when TcD peptide was used as antigen; 164 (91.6%) samples were positive with PEP2, and 178 (99.4%) samples were positive when the two peptides were combined. Thus, the sensitivity of the ELISA using the two peptides exceeded 99%. The specificity was evaluated by using a panel of 118 serum samples that included samples from 81 individuals living in an area of endemicity with negative serology for Chagas' disease and from 37 patients from areas in which T. cruzi was not endemic but with other pathologies, such as leishmaniasis, tuberculosis, and leprosy. Only two false-positive serum samples were found in this group of individuals, giving a test specificity of more than 98%. Because these peptides can be synthesized and are very stable at room temperature, the use of such reagents can improve the standardization and reproducibility of ELISAs for the serodiagnosis of T. cruzi infection.Keywords
This publication has 16 references indexed in Scilit:
- Trypanosoma cruzi: Characterization of Two Recombinant Antigens with Potential Application in the Diagnosis of Chagas′ DiseaseExperimental Parasitology, 1993
- Evaluation of recombinant trypomastigote surface antigens of Trypanosoma cruzi in screening sera from a population in rural Northeastern Brazil endemic for chagas' diseaseActa Tropica, 1992
- Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi.Proceedings of the National Academy of Sciences, 1992
- Chagas disease: epidemiology and prospects for interruption of transmission in the Americas.1992
- Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countriesTransfusion, 1991
- Structure and expression of two Trypanosoma cruzi genes encoding antigenic proteins bearing repetitive epitopesMolecular and Biochemical Parasitology, 1989
- Isolamento de amostras do Trypanosoma cruzi por xenodiagnóstico e hemocultura de pacientes na fase crônica da doença de ChagasMemórias do Instituto Oswaldo Cruz, 1989
- Multiple Trypanosoma cruzi antigens containing tandemly repeated amino acid sequence motifsMolecular and Biochemical Parasitology, 1988
- Effect of specific chemotherapy on the levels of lytic antibodies in Chagas's diseaseTransactions of the Royal Society of Tropical Medicine and Hygiene, 1982
- Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test.1966